-
The hearing of the US Senate version of the Biosafety Act is about to be held
On the morning of March 6th, local time, at a hearing held by the Homeland Security and Government Affairs Committee of the United States Senate, the Senate version of the Biosafety Act (No. S.3558) ... -
Baekje Shenzhou PD-1 has been approved by FDA as the second product in China after Junshi Biotechnology
Beijing, March 15th (Reporter Cao Qian, Intern Xie Xiaoxuan) Today, BeiGene announced that its PD-1 inhibitor, Tevimbra, has been approved by the FDA for the treatment of advanced or metastatic esoph ... -
Has the top student in the domestic CAR-T field received a merger offer? Legendary creature claims not to comment on rumors
On July 12th, it was reported that Legendary Biology had received a merger offer; After the news came out, the stock price of Legendary Biology fluctuated. On July 17th, Legendary Biology replied to ... -
Eni Group reportedly plans to sell up to 49% stake in its biomethane business
On October 20th, sources familiar with the matter said that Italian energy giant Eni Group plans to sell up to 49% of its biogas business Enibioch4in Spa and has hired French foreign trade bank to fi ... -
Yingen Biotech and GSK reach an exclusive licensing agreement worth approximately $1 billion
Yingen Biotechnology announced on December 4th that it has reached an exclusive licensing agreement with multinational pharmaceutical company GlaxoSmithKline (GSK) for a potential best in class ADC d ...